Role and regulation of dopamine D1 receptors in the striatum:: implications for the genesis of dyskinesia in Parkinson's disease.

被引:7
|
作者
Corvol, J. -C.
Girault, J. -A.
Herve, D.
机构
[1] CHU Pitie Salpetriere, Federat Malad Syst Nerveux, F-75651 Paris 13, France
[2] Inst Fer Moulin, UPMC, INSERM U536, Paris, France
关键词
D1 dopamine receptor; G protein; Parkinson's disease; dyskinesia;
D O I
10.1016/S0035-3787(06)75066-4
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
L-dopa treatment of Parkinson's disease is complicated in the long term by the appearance of dyskinesia. Hypersensitivity of D1 dopamine receptor has been suggested to play a role in these delayed adverse effects. Hypersensitivity of dopamine D1 receptor in Parkinson's disease can be accounted for by increased levels of G alpha olf, the stimulatory G protein which couples D I receptor to adenylyl cyclase in the striatum. We here discuss the possible role of D1 receptor signal transduction in the genesis of L-dopa-induced dyskinesia in the light of G alpha olf regulation.
引用
收藏
页码:691 / 702
页数:12
相关论文
共 50 条
  • [21] Dopamine receptors and BDNF-haplotypes predict dyskinesia in Parkinson's disease
    Kusters, Cynthia D. J.
    Paul, Kimberly C.
    Guella, Ilaria
    Bronstein, Jeff M.
    Sinsheimer, Janet S.
    Farrer, Matt J.
    Ritz, Beate R.
    [J]. PARKINSONISM & RELATED DISORDERS, 2018, 47 : 39 - 44
  • [22] Changes in Muscle Tone Are Regulated by D1 and D2 Dopamine Receptors in the Ventral Striatum and D1 Receptors in the Substantia Nigra
    Kim M Hemsley
    Ann D Crocker
    [J]. Neuropsychopharmacology, 2001, 25 : 514 - 526
  • [23] Changes in muscle tone are regulated by D1 and D2 dopamine receptors in the ventral striatum and D1 receptors in the substantia nigra
    Hemsley, KM
    Crocker, AD
    [J]. NEUROPSYCHOPHARMACOLOGY, 2001, 25 (04) : 514 - 526
  • [24] Proteomic Analysis of Changes Mediating Tolerance to Dopamine D1 Agonists: Implications for Parkinson's Disease (PD)
    Boyd, Kevin N.
    VanGuilder, Heather D.
    Freeman, Willard M.
    Mailman, Richard B.
    [J]. FASEB JOURNAL, 2011, 25
  • [25] Regulation of D1 receptor/DARPP-32 signaling by muscarinic receptors via the release of dopamine in the striatum
    Hieda, Eriko
    Hamada, Miho
    Kuroiwa, Mahomi
    Shuto, Takahide
    Nishi, Akinori
    [J]. JOURNAL OF PHARMACOLOGICAL SCIENCES, 2010, 112 : 186P - 186P
  • [26] Subregion-Specific Regulation of Dopamine D1 Receptor Signaling in the Striatum: Implication for L-DOPA-Induced Dyskinesia
    Sugiyama, Keita
    Kuroiwa, Mahomi
    Shuto, Takahide
    Ohnishi, Yoshinori N.
    Kawahara, Yukie
    Miyamoto, Yuta
    Fukuda, Takaichi
    Nishi, Akinori
    [J]. JOURNAL OF NEUROSCIENCE, 2021, 41 (30): : 6388 - 6414
  • [27] HETEROGENEOUS DISTRIBUTION OF DOPAMINE D1 AND D2 RECEPTORS IN THE HUMAN VENTRAL STRIATUM
    BERENDSE, HW
    RICHFIELD, EK
    [J]. NEUROSCIENCE LETTERS, 1993, 150 (01) : 75 - 79
  • [28] Motor skill learning mediated by D1 dopamine receptors in the striatum: Facilitation by cocaine
    Willuhn, I.
    Steiner, H.
    [J]. INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2006, 9 : S166 - S166
  • [29] The computational role of dopamine D1 receptors in working memory
    Durstewitz, D
    Seamans, JK
    [J]. NEURAL NETWORKS, 2002, 15 (4-6) : 561 - 572
  • [30] FROM RECEPTORS TO DRUGS - FOCUS ON THE ROLE OF D1 DOPAMINE (DA) RECEPTORS IN PARKINSONS-DISEASE
    KEBABIAN, JW
    DENINNO, MP
    BRITTON, D
    SCHOENLEBER, R
    SMITH, L
    JENNER, P
    WILLIAMS, M
    [J]. ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 1992, 203 : 1 - CHAS